Inactive Instrument

Biondvax Pharmaceuticals Ltd Stock

Stocks

End-of-day quote TEL AVIV STOCK EXCHANGE Other stock markets
- ^ILa	-

16/07/19	Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	PU
08/07/19	Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	PU
26/06/19	Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	PU
18/06/19	Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	PU
10/06/19	Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	PU

Manager	Title	Age	Since
Amir Reichman CEO	Chief Executive Officer	51	02/03/2021
Uri Ben-Or DFI	Director of Finance/CFO	54	01/01/2007
Dalit Fischer CTO	Chief Tech/Sci/R&D Officer	-	01/01/2022

Director	Title	Age	Since
Mark Germain CHM	Chairman	77	30/09/2019
Samuel Moed BRD	Director/Board Member	64	24/03/2020
Adi Raviv BRD	Director/Board Member	71	24/03/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.08%	-5.74%	-4.98%	+10.45%	46.06B
REVOLUTION MEDICINES, INC.	+3.13%	+5.34%	+402.93%	+605.08%	38.91B
BEONE MEDICINES AG	+2.14%	+2.95%	+10.83%	+65.45%	35.57B
IQVIA HOLDINGS INC.	+4.43%	-1.51%	+6.73%	-9.17%	33.13B
CELLTRION, INC.	+1.23%	-2.05%	+0.56%	+30.76%	26.42B
ASCENDIS PHARMA A/S	+0.29%	-2.75%	-	-	16.61B
MEDPACE HOLDINGS, INC.	+14.71%	+12.62%	+38.50%	+146.99%	15.08B
EUROFINS SCIENTIFIC SE	-6.32%	-4.86%	+4.36%	+8.22%	14.08B
ICON PUBLIC LIMITED COMPANY	+1.82%	+0.19%	+1.45%	-30.74%	12.81B
Average	+2.34%	-0.43%	+57.55%	+103.38%	26.52B
Weighted average by Cap.	+2.22%	-1.28%	+75.35%	+129.70%

Employees

Sector